ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Timothy Talbot, Fox Chase Founder, Centers Advocate, Dies At Age 72

November 11, 1988

Colorectal Cancer Incidence Rising Worldwide

June 12, 2009

New Health Bills Could Affect Cancer Program

February 9, 1979

FDA Encourages Study Of Gender Differences

August 6, 1993

In Brief: Innovative Antismoking Efforts Needed, CCRAC Told, Illinois To Go After Neutron Contract

December 8, 1978

Final Issue Of the Year

December 14, 1990